Department of Neurology, Medipulse Hospital, Jodhpur, Rajasthan, India.
Department of Pulmonary Medicine, Medipulse Hospital, Jodhpur, Rajasthan, India.
Indian J Med Res. 2020;152(1 & 2):41-47. doi: 10.4103/ijmr.IJMR_1395_20.
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been predominantly a respiratory manifestation. Currently, with evolving literature, neurological signs are being increasingly recognized. Studies have reported that SARS-CoV-2 affects all aspects of the nervous system including the central nervous system (CNS), peripheral nervous system (PNS) and the muscular system as well. Not all patients have reverse transcription-polymerase chain reaction positive for the virus in the cerebrospinal fluid, and diagnosing the association of the virus with the myriad of neurological manifestations can be a challenge. It is important that clinicians have a high-index of suspicion for COVID-19 in patients presenting with new-onset neurological symptoms. This will lead to early diagnosis and specific management. Further studies are desired to unravel the varied neurological manifestations, treatment, outcome and long-term sequel in COVID-19 patients.
由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的 COVID-19 大流行主要表现为呼吸道疾病。目前,随着文献的不断发展,人们越来越多地认识到神经系统的症状。研究报告称,SARS-CoV-2 影响神经系统的各个方面,包括中枢神经系统(CNS)、周围神经系统(PNS)和肌肉系统。并非所有患者的脑脊液中都能检测到病毒的逆转录-聚合酶链反应阳性,因此诊断病毒与众多神经系统表现之间的关联可能具有挑战性。重要的是,临床医生对出现新发神经系统症状的患者要高度怀疑 COVID-19。这将导致早期诊断和针对性治疗。还需要进一步的研究来阐明 COVID-19 患者的各种神经系统表现、治疗、结果和长期后遗症。